| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |